Dan Lemaitre is the founder of BlueWind Medical. BlueWind Medical has raised $64M in total funding. Latest round: Series B. Backed by ConvaTec.
Dan Lemaitre is the Chief Executive Officer of BlueWind Medical, a medical technology company developing the RENOVA iStim implantable tibial neuromodulation device. He was appointed CEO in 2021 and successfully led the company through a $64 million Series B funding round in May 2022.
Full founder directory · Investor directory · Company funding database · Fundraising library